Multiple risk factors for high-dose chemotherapy

被引:0
|
作者
J Sarrá
P Vivancos
R Sola
A Grañena
机构
[1] Centre d’Hematologia,
[2] Clínica Corachan,undefined
[3] Nephrology Service,undefined
[4] Fundación Puigvert,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:933 / 933
相关论文
共 50 条
  • [1] Multiple risk factors for high-dose chemotherapy
    Sarrá, J
    Vivancos, P
    Sola, R
    Grañena, A
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 (09) : 933 - 933
  • [2] High-dose chemotherapy and multiple sclerosis
    Harrison, Daniel
    Gladstone, Douglas E.
    [J]. CURRENT OPINION IN ONCOLOGY, 2011, 23 (02) : 221 - 226
  • [3] High-dose chemotherapy for multiple myeloma
    不详
    [J]. AMERICAN JOURNAL OF NURSING, 2003, 103 (08) : 19 - 19
  • [4] High-dose chemotherapy in multiple myeloma
    Goldschmidt, H
    Hegenbart, U
    Wallmeier, M
    Moos, M
    Haas, R
    [J]. LEUKEMIA, 1997, 11 : S27 - S31
  • [5] High-dose chemotherapy in multiple myeloma
    Oivanen, TM
    Palva, IP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (24): : 1844 - 1845
  • [6] High-dose chemotherapy for multiple myeloma
    Fermand, JP
    Ravaud, P
    [J]. PRESSE MEDICALE, 1997, 26 (11): : 521 - 524
  • [7] High-dose chemotherapy in multiple myeloma
    Gahrton, G
    Bjorkstrand, B
    [J]. EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY - 21ST ESMO CONGRESS, EDUCATIONAL BOOK, 1996, : 165 - 170
  • [8] High-dose chemotherapy in multiple myeloma - Reply
    Attal, M
    Harousseau, JL
    Bataille, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (24): : 1845 - 1845
  • [9] Maculopapular skin rashes associated with high-dose chemotherapy: Prevalence and risk factors
    Wright, Lynette G.
    [J]. ONCOLOGY NURSING FORUM, 2006, 33 (06) : 1095 - 1103
  • [10] Multiple cycles of high-dose chemotherapy for ovarian cancer
    Schilder, RJ
    Shea, TC
    [J]. SEMINARS IN ONCOLOGY, 1998, 25 (03) : 349 - 355